Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. FIVE
5. HPE
6. VRTS
7. NTAP
8. NTSK
9. OLLI
10. CRWD

Go back to Pfizer’s ZAVZPRET™ (zavegepant) Migraine Nasal Spray Receives FDA Approval
Pfizer Inc. (NYSE: PFE) Delayed: 29.02 --0 (-0%)
Previous Close $29.02    52 Week High $37.39 
Open $29.02    52 Week Low $28.25 
Day High $29.02    P/E 17.59 
Day Low $29.02    EPS $1.65 
Volume 64,593       

Pfizer Inc. (NYSE: PFE) Delayed: 29.02 --0 (-0%)
Previous Close $29.02    52 Week High $37.39 
Open $29.02    52 Week Low $28.25 
Day High $29.02    P/E 17.59 
Day Low $29.02    EPS $1.65 
Volume 64,593